SignatureFD’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

SignatureFD’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-569	Closed	-$504	–	3430
2022 Q4	$504	Buy	+569	New	+$755	﹤0.01%	3109
2022 Q2	–	Sell	-1,724	Closed	-$4K	–	3427
2022 Q1	$4K	Buy	+1,724	New	+$5.38K	﹤0.01%	2638
2021 Q4	–	Sell	-191	Closed	-$1K	–	3339
2021 Q3	$1K	Buy	+191	New	+$1.62K	﹤0.01%	2983
2021 Q2	–	Sell	-510	Closed	-$4K	–	3112
2021 Q1	$4K	Buy	+510	New	+$5.38K	﹤0.01%	2292
2020 Q3	–	Sell	-459	Closed	-$3K	–	2806
2020 Q2	$3K	Buy	+459	New	+$1.76K	﹤0.01%	2048

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

SignatureFD's SRNE Position: Q1 2023 in Review

SignatureFD sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 569 shares — an estimated $504 sold.

SignatureFD first reported a position in SRNE in Q2 2020 and held it in 5 quarters. The position peaked at $4K in Q1 2022. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

SignatureFD reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
SignatureFD sold 569 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $504.
SignatureFD first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 5 quarters.
SignatureFD's Sorrento Therapeutics, Inc. position peaked at $4K in Q1 2022.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on SignatureFD's 13F filing for Q1 2023, filed 28 Apr 2023.